Robert S Breuil insider trades: CalciMedica (GRAY) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | GRAY | ↓ Sell | 2,188 | $1.25 | $3K | Direct | Apr 4, 2022 (4d) |
| Sep 22, 2021 | GRAY | ↓ Sell | 7,283 | $3.55 | $26K | Direct | Sep 24, 2021 (2d) |
| Aug 17, 2018 | CORI | ↓ Sell | 972 | $9.01 | $9K | Direct | Aug 17, 2018 (0d) |
| Nov 24, 2014 | CORI | ↑ Buy | 4,600 | $5.38 | $25K | Direct | Nov 24, 2014 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Robert S Breuil's insider trades
Robert S Breuil is Chief Financial Officer at CalciMedica (GRAY). Since Nov 24, 2014, Robert has reported 1 open-market purchase worth $25K and 3 sales worth $37K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (13 filings), shares withheld for taxes (9 filings), grants and awards (9 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GRAY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.